A genetic compensatory mechanism regulated by Jun and Mef2d modulates the expression of distinct class IIa Hdacs to ensure peripheral nerve myelination and repair

Abstract

The class IIa histone deacetylases (HDACs) have pivotal roles in the development of different tissues. Of this family, Schwann cells express Hdac4, 5 and 7 but not Hdac9. Here we show that a transcription factor regulated genetic compensatory mechanism within this family of proteins, blocks negative regulators of myelination ensuring peripheral nerve developmental myelination and remyelination after injury. Thus, when Hdac4 and 5 are knocked-out from Schwann cells in mice, a JUN-dependent mechanism induces the compensatory overexpression of Hdac7 permitting, although with a delay, the formation of the myelin sheath. When Hdac4,5 and 7 are simultaneously removed, the Myocyte-specific enhancer-factor d (MEF2D) binds to the promoter and induces the de novo expression of Hdac9, and although several melanocytic lineage genes are misexpressed and Remak bundle structure is disrupted, myelination proceeds after a long delay. Thus, our data unveil a finely tuned compensatory mechanism within the class IIa Hdac family, coordinated by distinct transcription factors, that guarantees the ability of Schwann cells to myelinate during development and remyelinate after nerve injury.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file

Article and author information

Author details

  1. Sergio Velasco-Aviles

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    Competing interests
    The authors declare that no competing interests exist.
  2. Nikiben Patel

    Laboratorio 117, Instituto de Neurociencias de Alicante UMH-CSIC, San Juan, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0129-7622
  3. Angeles Casillas-Bajo

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    Competing interests
    The authors declare that no competing interests exist.
  4. Laura Frutos-Rincón

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    Competing interests
    The authors declare that no competing interests exist.
  5. Enrique Velasco-Serna

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    Competing interests
    The authors declare that no competing interests exist.
  6. Juana Gallar

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    Competing interests
    The authors declare that no competing interests exist.
  7. Peter Arthur-Farraj

    Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1239-9392
  8. Jose A Gomez-Sanchez

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    For correspondence
    j.gomez@umh.es
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6746-1800
  9. Hugo Cabedo

    Instituto de Neurociencias de Alicante UMH-CSIC, Alicante, Spain
    For correspondence
    hugo.cabedo@umh.es
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1322-6290

Funding

Ministerio de Economía y Competitividad (BFU2016-75864R)

  • Hugo Cabedo

Ministerio de Economía y Competitividad (PID2019-109762RB-I00)

  • Hugo Cabedo

ISABIAL (UGP18-257)

  • Hugo Cabedo

ISABIAL (UGP-2019-128)

  • Hugo Cabedo

Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana (PROMETEO 2018/114)

  • Juana Gallar
  • Hugo Cabedo

Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana (ACIF/2 017/169)

  • Laura Frutos-Rincón

Ministerio de Educación, Cultura y Deporte (FPU16/00283)

  • Enrique Velasco-Serna

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal work was conducted according to European Union guidelines and with protocols approved by the Comité de Bioética y Bioseguridad del Instituto de Neurociencias de Alicante, Universidad Hernández de Elche and Consejo Superior de Investigaciones Científicas (http://in.umh.es/). Reference number for the aproved protocol: 2017/VSC/PEA/00022 tipo 2.

Copyright

© 2022, Velasco-Aviles et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,618
    views
  • 248
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sergio Velasco-Aviles
  2. Nikiben Patel
  3. Angeles Casillas-Bajo
  4. Laura Frutos-Rincón
  5. Enrique Velasco-Serna
  6. Juana Gallar
  7. Peter Arthur-Farraj
  8. Jose A Gomez-Sanchez
  9. Hugo Cabedo
(2022)
A genetic compensatory mechanism regulated by Jun and Mef2d modulates the expression of distinct class IIa Hdacs to ensure peripheral nerve myelination and repair
eLife 11:e72917.
https://doi.org/10.7554/eLife.72917

Share this article

https://doi.org/10.7554/eLife.72917

Further reading

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bhumil Patel, Maryke Grobler ... Needhi Bhalla
    Research Article

    Meiotic crossover recombination is essential for both accurate chromosome segregation and the generation of new haplotypes for natural selection to act upon. This requirement is known as crossover assurance and is one example of crossover control. While the conserved role of the ATPase, PCH-2, during meiotic prophase has been enigmatic, a universal phenotype when pch-2 or its orthologs are mutated is a change in the number and distribution of meiotic crossovers. Here, we show that PCH-2 controls the number and distribution of crossovers by antagonizing their formation. This antagonism produces different effects at different stages of meiotic prophase: early in meiotic prophase, PCH-2 prevents double-strand breaks from becoming crossover-eligible intermediates, limiting crossover formation at sites of initial double-strand break formation and homolog interactions. Later in meiotic prophase, PCH-2 winnows the number of crossover-eligible intermediates, contributing to the designation of crossovers and ultimately, crossover assurance. We also demonstrate that PCH-2 accomplishes this regulation through the meiotic HORMAD, HIM-3. Our data strongly support a model in which PCH-2’s conserved role is to remodel meiotic HORMADs throughout meiotic prophase to destabilize crossover-eligible precursors and coordinate meiotic recombination with synapsis, ensuring the progressive implementation of meiotic recombination and explaining its function in the pachytene checkpoint and crossover control.

    1. Cell Biology
    Jingjing Li, Xinyue Wang ... Vincent Archambault
    Research Article

    In animals, mitosis involves the breakdown of the nucleus. The reassembly of a nucleus after mitosis requires the reformation of the nuclear envelope around a single mass of chromosomes. This process requires Ankle2 (also known as LEM4 in humans) which interacts with PP2A and promotes the function of the Barrier-to-Autointegration Factor (BAF). Upon dephosphorylation, BAF dimers cross-bridge chromosomes and bind lamins and transmembrane proteins of the reassembling nuclear envelope. How Ankle2 functions in mitosis is incompletely understood. Using a combination of approaches in Drosophila, along with structural modeling, we provide several lines of evidence that suggest that Ankle2 is a regulatory subunit of PP2A, explaining how it promotes BAF dephosphorylation. In addition, we discovered that Ankle2 interacts with the endoplasmic reticulum protein Vap33, which is required for Ankle2 localization at the reassembling nuclear envelope during telophase. We identified the interaction sites of PP2A and Vap33 on Ankle2. Through genetic rescue experiments, we show that the Ankle2/PP2A interaction is essential for the function of Ankle2 in nuclear reassembly and that the Ankle2/Vap33 interaction also promotes this process. Our study sheds light on the molecular mechanisms of post-mitotic nuclear reassembly and suggests that the endoplasmic reticulum is not merely a source of membranes in the process, but also provides localized enzymatic activity.